alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS MARCH 31, 1999, AND THE STATEMENTS OF OPERATIONS FOR THE THREE MONTHS
ENDED MARCH 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                         720,300
<SECURITIES>                                         0
<RECEIVABLES>                                   52,300
<ALLOWANCES>                                     5,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       8,464,100
<DEPRECIATION>                               5,591,500
<TOTAL-ASSETS>                               4,716,100
<CURRENT-LIABILITIES>                          930,900
<BONDS>                                      1,350,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 4,716,100
<SALES>                                              0
<TOTAL-REVENUES>                               867,600
<CGS>                                                0
<TOTAL-COSTS>                                  820,700
<OTHER-EXPENSES>                               (6,000)
<LOSS-PROVISION>                                 6,300
<INTEREST-EXPENSE>                              37,200
<INCOME-PRETAX>                                 15,700
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             15,700
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    15,700
<EPS-PRIMARY>                                      .19
<EPS-DILUTED>                                        0
        

</TABLE>
---

Exhibit 99.1



---



---



---



---



---



---



---



*A portion of this subsection
describing the collateral has been omitted pursuant to 
Rule 24b-2 of the Securities and Exchange Act of 1934, as amended.
Such omitted section has been filed separately with the 
SEC pursuant to a request for confidential treatment.

---



---



---



*A portion of this subsection describing the collateral
has been omitted pursuant to 
Rule 24b-2 of the Securities and Exchange Act of 1934, as amended.
Such omitted section has been filed separately with the 
SEC pursuant to a request for confidential treatment.

---



*A portion of this subsection describing the collateral
has been omitted pursuant to 
Rule 24b-2 of the Securities and Exchange Act of 1934, as amended.
Such omitted section has been filed separately with the 
SEC pursuant to a request for confidential treatment.

---
EXHIBIT 13.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Annual Report of LanOptics Ltd. (the
"Company") on Form 20-F for the period ending December 31, 2006 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I, Eli
Fruchter, Chairman of the Board of Directors of the Company, certify, pursuant
to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act
of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

                                                     Date: March 29, 2007

                                                     By: /S/ ELI FRUCHTER
                                                     --------------------
                                                     Eli Fruchter
                                                     Principal Executive Officer

* The originally executed copy of this Certification will be maintained at the
Company's offices and will be made available for inspection upon request.
EXHIBIT 23 (i)

   Consent of Independent Accountant







   We have issued our reports dated February 10, 1998, accompanying the
   consolidated financial statements and schedule incorporated by reference
   in the Annual Report of Badger Paper Mills, Inc. and Subsidiary on Form
   10-K for the year ended December 31, 1997.  We hereby consent to the
   incorporation by reference of said reports in the Registration Statements
   of Badger Paper Mills, Inc. and Subsidiary on Forms S-8 (File No. 333-
   01671, effective March 13, 1996 and File No. 333-01673, effective March
   13, 1996).





                                 /s/  GRANT THORNTON, L.L.P.


   Appleton, Wisconsin
   March 27, 1998
[Federal Register Volume 74, Number 116 (Thursday, June 18, 2009)]
[Notices]
[Page 28957]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14324]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-63,439]


Watson Laboratories, Inc., a Connecticut Corporation, Including 
Workers Located Off-Site in Danbury, CT, Carmel, NY; Amended 
Certification Regarding Eligibility To Apply for Worker Adjustment 
Assistance and Alternative Trade Adjustment Assistance

    In accordance with Section 223 of the Trade Act of 1974 (19 U.S.C 
2273), and Section 246 of the Trade Act of 1974 (26 U.S.C. 2813), as 
amended, the Department of Labor issued a Certification of Eligibility 
to Apply for Worker Adjustment Assistance and Alternative Trade 
Adjustment Assistance on January 23, 2009, applicable to workers of 
Watson Laboratories, Inc., a Connecticut Corporation, Carmel, New York. 
The notice was published in the Federal Register on July 14, 2009 (73 
FR 135).
    At the request of the company official, the Department reviewed the 
certification for workers of the subject firm. The workers produce 
pharmaceuticals and medicines. New information provided by the company 
shows that the worker group included workers located off-site at an 
affiliated facility in Danbury, Connecticut.
    The intent of the Department's certification is to include all 
workers at the subject firm who were adversely affected by the shift in 
production of pharmaceuticals and medicines to India and their 
subsequent import.
    The Department has determined that the workers located in Carmel, 
New York and the workers located in Danbury, Connecticut are not 
separately identifiable by product.
    Based on these findings, the Department is amending this 
certification to include workers of the subject firm working off-site 
at the Danbury, Connecticut location of the subject firm.
    The amended notice applicable to TA-W-64,439 is hereby issued as 
follows:

    ``All workers of Watson Laboratories Inc., a Connecticut 
Corporation, including workers located off-site in Danbury, 
Connecticut, Carmel, New York, who became totally or partially 
separated from employment on or after May 27, 2007 through two years 
from the date of certification are eligible to apply for adjustment 
assistance under Section 223 of the Trade Act of 1974, and are also 
eligible to apply for alternative trade adjustment assistance under 
Section 246 of the Trade Act of 1974.''

    Signed in Washington, DC, this 18th day of May 2009.
Richard Church,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E9-14324 Filed 6-17-09; 8:45 am]
BILLING CODE 4510-FN-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
QUARTERLY FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 1995 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1994
<PERIOD-END>                               SEP-30-1995
<CASH>                                         650,270
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               650,270
<PP&E>                                       2,826,280
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               3,476,830
<CURRENT-LIABILITIES>                           50,051
<BONDS>                                      4,992,422
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                 (1,565,643)
<TOTAL-LIABILITY-AND-EQUITY>                 3,476,830
<SALES>                                        759,010
<TOTAL-REVENUES>                               772,558
<CGS>                                          555,773
<TOTAL-COSTS>                                  614,980
<OTHER-EXPENSES>                                41,779
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             261,951
<INCOME-PRETAX>                              (146,152)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (146,152)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (146,152)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-QSB
FOR MARCH 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                         644,676
<SECURITIES>                                         0
<RECEIVABLES>                                   82,479
<ALLOWANCES>                                     1,406
<INVENTORY>                                     41,597
<CURRENT-ASSETS>                               893,665
<PP&E>                                       1,956,023
<DEPRECIATION>                                 293,205
<TOTAL-ASSETS>                               2,675,264
<CURRENT-LIABILITIES>                          462,584
<BONDS>                                        346,813
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        64,336
<OTHER-SE>                                   1,801,531
<TOTAL-LIABILITY-AND-EQUITY>                 2,675,264
<SALES>                                         61,170
<TOTAL-REVENUES>                               131,483
<CGS>                                          131,670
<TOTAL-COSTS>                                  204,813
<OTHER-EXPENSES>                                50,507
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,635
<INCOME-PRETAX>                              (436,492)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (436,492)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (436,492)
<EPS-PRIMARY>                                   (.008)
<EPS-DILUTED>                                   (.008)
        

</TABLE>
#### In re: Mark Henry FOSS, Debtor. Mark Henry Foss, Appellant, v. Hall County Child Support Office, Appellee.

No. 05-2763.

United States Court of Appeals, Eighth Circuit.

Submitted: June 23, 2006.

Filed: June 26, 2006.

Mark Henry Foss, Grand Island, NE, pro se.

Michelle J. Oldham, Hall County Attorney, Grand Island, NE, for Appellee.

Before MELLOY, FAGG, and BENTON, Circuit Judges.

PER CURIAM.

Mark Foss appeals from the Bankruptcy Appellate Panel’s (BAP) decision affirming the bankruptcy court’s1 dismissal of his adversary proceeding with prejudice. We agree with the BAP that the bankruptcy court abstained from hearing the issues raised by Foss in his pending state court proceedings. *See*28 U.S.C. § 1334(b)— (c)(1) (generally, federal courts have original but not exclusive jurisdiction of all civil proceedings arising under title 11, or arising in or related to cases under title 11, but may abstain from hearing such proceeding in interest of comity with state courts or respect for state law). Accordingly, we do not have jurisdiction to review the bankruptcy court’s decision to abstain. *See*28 U.S.C. § 1334(d) (decision to abstain under § 1334(c)(1) is not reviewable by courts of appeals). We therefore dismiss this appeal.

1

. The Honorable Timothy J. Mahoney, Chief Judge, United States Bankruptcy Court for the District of Nebraska.
AMENDMENT TO


INVESTMENTAGREEMENT


 


THIS AMENDMENT TO INVESTMENT
AGREEMENT (the “Amendment”) is made and entered into as of July 8, 2013, by
and among Vaccinogen, Inc., a Maryland corporation (the “Company”) and Kodiak Capital Group, LLC, a Delaware
limited liability company (collectively, the “Investor”). The Company and the Investor are collectively
referred to as the “Parties.”


 


RECITALS


 


WHEREAS, on or about July 18, 2012, the Company and Investor
entered into an Investment Agreement, which Investment Agreement (the “Investment Agreement”) pursuant to which
the Investor agreed to up to twenty five million dollars ($25,000,000) to purchase the Company’s Common Stock, $0.0001 par
value per share (the “Common Stock”) on the terms and conditions set forth in the Investment Agreement.
The Agreement is incorporated into this Amendment by this reference and all defined terms in the Agreement shall have the same
meaning in this Amendment.


 


WHEREAS, the
Parties now wish to modify and amend the Investment Agreement to increase the amount to be invested by to the Investor to twenty-six
million ($26,000,000) in accordance with this Amendment.


 


AGREEMENT


 


NOW, THEREFORE,
in consideration of the foregoing, and for other good and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the Parties hereto agree as follows:


 


AGREEMENT


 


1.           Incorporation
of Recitals . The Recitals set forth above are herein incorporated into this Amendment.


 


2.           Section
1-Definitions. Section 1 of the Investment Agreement shall be amended as follows:


 


a.           The
definition of “Facility Amount” shall be amended to read in its entirety as follows:


 


“Facility
Amount” shall mean twenty six million dollars ($26,000,000).”


 


3.           Section
2(A)—Purchase and Sale of Common Stock. Section 2(A) of the Investment Agreement shall be amended by deleting the
term “twenty five million dollars ($25,000,000)” and inserting “twenty six million dollars ($26,000,000)”
in lieu thereof.


 




    	1



    	 



    

 


3.           Amendment.
This Amendment shall be deemed an amendment of the Investment Agreement in accordance with Section 12(F) of the Investment Agreement.


 


4.           Counterparts.
This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument.


 




    	2



    	 



    

 


IN WITNESS WHEREOF,
the Parties hereto, intending to be legally bound, have each executed this Amendment on the dates set forth above.


 


	 	COMPANY:
	 	 
	 	Vaccinogen, Inc.
	 	 
	 	By:	/s/ Michael G. Hanna, Jr. Ph.D.
	 	Michael G. Hanna, Jr., Ph.D.
	 	Chairman and Chief Executive Officer
	 	 
	 	INVESTOR:
	 	 
	 	Kodiak Capital Group, LLC
	 	 
	 	By:	/s/ Ryan Hodson
	 	Ryan Hodson
	 	Managing Director


 




    	3
# Past NAMHC Meetings

To obtain a copy of NAMHC meeting minutes prior to 2018, please contact the nimhwebmaster@mail.nih.gov.
EXHIBIT 23











CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM








We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 2-72576) pertaining to the 1981 Stock Purchase Plan, the Registration Statement (Form S-8 No. 33-34107) pertaining to the Baldwin & Lyons, Inc. Deferred Directors Fee Option Plan, and the Registration Statement (Form S-8 No 33-31316) pertaining to the Baldwin & Lyons, Inc. Employee Discounted Stock Option Plan of our reports dated March 11, 2011, with respect to the consolidated financial statements and schedules of Baldwin & Lyons, Inc. and subsidiaries, and the effectiveness of internal control over financial reporting of Baldwin & Lyons, Inc. and subsidiaries included in the Annual Report (Form 10-K) for the year ended December 31, 2010.











/S/ ERNST & YOUNG LLP








Indianapolis, Indiana


March 11, 2011


- 83 -
#### Arnold D. WADLER, Plaintiff, v. MEDITERRANEAN LINES, Inc., Defendant. Arnold D. WADLER, Plaintiff, v. COSMOPOLITAN SHIPPING CO., Inc., and Home Lines, Inc., Defendants.

United States District Court S. D. New York.

May 17, 1954.

H. Sidney Bergman and Jacob Rassner, New York City, for plaintiff. McNutt & Nash, for defendants.

DIMOCK, District Judge.

These are motions to dismiss the complaint for failure to substitute as plain*323tiff the administrator of the estate of the deceased plaintiff, within two years after the death of the plaintiff, as required by Rule 25(a), Fed.Rules Civ. Proc. 28 TJ.S.C. In an earlier memorandum on these motions, I pointed out that, since the actions are to enforce state-created rights, it is arguable that New York law should be applied. See 4 Moore’s Federal Practice (2d ed.) pp. 522-23. I therefore gave counsel for plaintiff an opportunity to submit within 10 days an affidavit setting forth any facts which would prevent dismissal of the actions under the law of New York.

The ten-day period has elapsed with no communication from counsel for plaintiff. Since I have not been shown that the New York law prescribes a different result, I grant the defendants’ motions without deciding whether Rule 25 (a) F.R.C.P. imposes a mandatory two year limitation in diversity cases.

Complaints dismissed.
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             317
<SECURITIES>                                         0
<RECEIVABLES>                                      400
<ALLOWANCES>                                         0
<INVENTORY>                                        170
<CURRENT-ASSETS>                                   904
<PP&E>                                           7,066
<DEPRECIATION>                                 (3,976)
<TOTAL-ASSETS>                                   4,955
<CURRENT-LIABILITIES>                            2,743
<BONDS>                                             29
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,596
<OTHER-SE>                                     (8,414)
<TOTAL-LIABILITY-AND-EQUITY>                     4,955
<SALES>                                            795
<TOTAL-REVENUES>                                   795
<CGS>                                            1,328
<TOTAL-COSTS>                                    2,963
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   9
<INCOME-PRETAX>                                (2,176)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,176)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,176)
<EPS-BASIC>                                   (0.24)
<EPS-DILUTED>                                   (0.24)




</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM OROAMERICA,
INC.'S CONSOLIDATED BALANCE SHEET AT MAY 2,1997 (UNAUDITED) AND CONSOLIDATED
STATEMENT OF INCOME FOR THE THIRTEEN WEEKS ENDED MAY 2, 1997 (UNAUDITED) AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-30-1998
<PERIOD-END>                               MAY-02-1997
<CASH>                                          19,601
<SECURITIES>                                         0
<RECEIVABLES>                                   21,143
<ALLOWANCES>                                     6,144
<INVENTORY>                                     11,053
<CURRENT-ASSETS>                                50,091
<PP&E>                                          21,353
<DEPRECIATION>                                  10,884
<TOTAL-ASSETS>                                  71,984
<CURRENT-LIABILITIES>                            9,447
<BONDS>                                          2,590
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             6
<OTHER-SE>                                      59,656
<TOTAL-LIABILITY-AND-EQUITY>                    71,984
<SALES>                                         32,650
<TOTAL-REVENUES>                                32,650
<CGS>                                           26,439
<TOTAL-COSTS>                                   26,439
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                    41
<INTEREST-EXPENSE>                                 426
<INCOME-PRETAX>                                    261
<INCOME-TAX>                                       118
<INCOME-CONTINUING>                                143
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       143
<EPS-PRIMARY>                                      .02
<EPS-DILUTED>                                      .02
        

</TABLE>